** Shares of telehealth firm Doximity DOCS.N rise 8.7% to $63.74 premarket
** Late on Thursday, company raised FY26 sales forecast to between $628 mln and $636 mln, from $619 mln and $631 mln projected earlier
** Analysts estimate FY26 sales at be $628 mln - data compiled by LSEG
** Q1 sales of $145.9 mln above estimate of $139.5 mln
** Q1 adjusted EPS of 36 cents compares with estimate of 30 cents
** Separately, Doximity acquires Montreal-based Pathway Medical, an AI-driven clinical reference startup, for up to $63 mln
** As of last close, stock up 9.6% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.